Cart
sales@molnova.com
Home - Products - Others - Other Targets - 4-Pyridoxic Acid

4-Pyridoxic Acid

CAS No. 82-82-6

4-Pyridoxic Acid( —— )

Catalog No. M19152 CAS No. 82-82-6

4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    4-Pyridoxic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.
  • Description
    4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VB6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82-82-6
  • Formula Weight
    183.16
  • Molecular Formula
    C8H9NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (27.30 mMult)
  • SMILES
    CC1=NC=C(C(=C1O)C(=O)O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shibata K, et al. Urinary excretion levels of water-soluble vitamins in pregnant and lactating women in Japan[J]. Journal of Nutritional Science & Vitaminology, 2013, 59(3):178-86.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • ICCB280

    ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.

  • Parimifasor

    Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).

  • SB-216

    SB-216 is able to be used for the research of cancer which is a potent inhibitor of tubulin polymerization.

Sign In Join Free